SCHEMBL6443725

SCHEMBL6443725

CCCCCCC(Cc1ccc(F)cc1F)NC(=O)COc1ccc(CCOc2ccccc2C(=O)OC)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 12/20 0.44
HSP90AA1 P07900 2/20 0.43
MAPT P10636 2/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38
PPARG P37231 1/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4964263 0.81 HSP90AA1 (0.44) HSP90AA1MAPTHTTNPSR1ALDH1A1
SCHEMBL4961998 0.76 KDM4E (0.43) HSP90AA1MAPTHTTNPSR1ALDH1A1
SCHEMBL4961660 0.74 PPARG (0.45) NPSR1ALDH1A1CYP2C9PPARG
SCHEMBL3963763 0.70 PPARA (0.45) PPARG
SCHEMBL4964264 0.67 KDM4E (0.41) ALDH1A1PPARG
SCHEMBL9321710 0.67 SIGMAR1 (0.53) SIGMAR1ALDH1A1SMN1; SMN2PTGESALOX5
SCHEMBL9321708 0.67 SIGMAR1 (0.53) SIGMAR1ALDH1A1SMN1; SMN2PTGESALOX5
SCHEMBL4964423 0.67 HTR2A (0.42) MAPTHTT
SCHEMBL9321687 0.66 SIGMAR1 (0.50) SIGMAR1
SCHEMBL9320258 0.66 SIGMAR1 (0.50) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517679-A1 ORTHO-SUBSTITUTED BENZOIC ACID DERIVATIVES FOR THE TREATMENT OF INSULIN RESISTANCE AstraZeneca AB (SE) 2005-03-30 EP disclosed
WO-2004000294-A1 ORTHO-SUBSTITUTED BENZOIC ACID DERIVATIVES FOR THE TREATMENT OF INSULIN RESISTANCE ASTRAZENECA AB (SE) 2003-12-31 WO disclosed